Cinnamon contains compounds that show kidney-protective effects in laboratory and animal research, but the human evidence is thin and no medical guideline recommends cinnamon as a treatment for kidney disease. A 2023 narrative review in Kidney Research and Clinical Practice described cinnamon as a potential “additional nutritional strategy” for people with chronic kidney disease (CKD), noting that its bioactive compounds can counteract several complications common in CKD. That framing captures where the science sits right now: interesting enough to study further, far from proven enough to prescribe.
What Lab and Animal Studies Have Found
Most of the excitement around cinnamon and kidneys comes from experiments in cell cultures and rodents, not from trials in people. A consistent finding across these studies is that cinnamon’s active compounds reduce the buildup of harmful molecules called advanced glycation endproducts (AGEs). AGEs form when sugars react with proteins, and they accumulate faster when blood sugar stays elevated. In kidneys, AGE buildup damages the tiny filtering units and accelerates the progression of diabetic kidney disease. A study in diabetic rats found that both whole cinnamon extract and a procyanidin-B2 enriched fraction from cinnamon inhibited AGE accumulation in the kidney and improved markers of diabetic kidney damage.1PubMed. Effect of cinnamon and its procyanidin-B2 enriched fraction on diabetic nephropathy in rats Separately, laboratory work showed that cinnamon proanthocyanidins block the formation of specific AGEs by acting as both antioxidants and scavengers of reactive sugar byproducts.2PubMed. Beneficial effects of cinnamon proanthocyanidins on the formation of specific advanced glycation endproducts and methylglyoxal-induced impairment on glucose consumption
Another thread of animal research involves acute kidney injury, the kind that happens when blood flow to the kidneys is suddenly cut off and then restored (called ischemia-reperfusion). In mice, trans-cinnamaldehyde, the main flavor compound in cinnamon bark, significantly reduced kidney inflammation and injury markers after this type of damage. The effect appeared to work by suppressing inflammatory signaling pathways inside kidney cells.3PubMed. Trans-cinnamaldehyde attenuates renal ischemia/reperfusion injury through suppressing inflammation via JNK/p38 MAPK signaling pathway These findings are genuinely interesting to researchers, but mice injected with a purified compound under controlled conditions are a long way from a person sprinkling cinnamon on oatmeal.
The Slim Human Evidence
Only a handful of clinical trials have measured any kidney-related outcome in people taking cinnamon, and the most cited one focused primarily on diabetes, not kidneys. In that study, people with type 2 diabetes received cinnamon supplementation for 60 days. Along with expected improvements in blood sugar and cholesterol, the cinnamon group showed a statistically significant increase in estimated glomerular filtration rate (eGFR), a standard measure of how well the kidneys filter blood.4PubMed Central. Effect of cinnamon supplementation on glucose, lipids levels, glomerular filtration rate, and blood pressure of subjects with type 2 diabetes mellitus A higher eGFR generally signals better kidney function. Blood pressure also dropped significantly in the cinnamon group, which matters because high blood pressure is one of the main drivers of kidney decline in diabetic patients.
That said, this was a small trial, and the eGFR improvement could have been partly explained by the blood-sugar and blood-pressure reductions themselves rather than a direct kidney-protective effect. Lowering blood sugar and blood pressure are among the most reliable ways to slow kidney damage in diabetes. No large randomized trial has yet tested cinnamon specifically to prevent or slow CKD progression, so it is impossible to say from human data alone whether cinnamon does anything beyond what better metabolic control would accomplish on its own.
The Broader Theory for Chronic Kidney Disease
A 2023 review paper laid out the theoretical case for why cinnamon might help people with CKD. The argument rests on the fact that CKD patients tend to develop a cluster of interconnected problems: chronic inflammation, oxidative stress, high blood sugar (even in those without diabetes), abnormal blood lipids, and an imbalanced gut microbiome. Cinnamon’s bioactive compounds, particularly cinnamaldehyde, cinnamic acid, and cinnamate, have been shown in various laboratory contexts to address each of those problems.5PubMed Central. Cinnamon: an aromatic condiment applicable to chronic kidney disease The review positioned cinnamon not as a treatment but as a possible nutritional add-on for CKD patients, acknowledging that clinical trials designed specifically for this population are still needed.
The gut connection is one of the more intriguing angles. As kidney function declines, toxins that healthy kidneys would filter out accumulate in the bloodstream and change the composition of gut bacteria. That disturbed gut environment, in turn, produces additional toxins that further damage the kidneys. Researchers are increasingly interested in foods and supplements that could interrupt this cycle. Cinnamon’s antimicrobial and prebiotic-like properties have been studied in other contexts, and the CKD review flagged gut dysbiosis as one of the complications cinnamon’s compounds could theoretically address.5PubMed Central. Cinnamon: an aromatic condiment applicable to chronic kidney disease But “theoretically” is carrying a lot of weight in that sentence. No study has specifically tracked gut microbiome changes in CKD patients taking cinnamon.
Cinnamon and Kidney Stones
People with kidney stones or a history of them often worry about oxalate, a compound found in many plants that can crystallize in the kidneys and form stones. Cinnamon gets lumped in with other spices assumed to be high in oxalate, but the evidence here is actually reassuring. A study in healthy subjects compared the effect of supplemental doses of cinnamon and turmeric on urinary oxalate levels. Turmeric significantly raised urinary oxalate and increased kidney stone risk in susceptible people, but cinnamon did not. The difference came down to the form of oxalate in each spice: about 91% of the oxalate in turmeric was water-soluble and readily absorbed, while only about 6% of the oxalate in cinnamon was water-soluble.6PubMed. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects So if you are prone to calcium-oxalate kidney stones, cinnamon appears to be a much safer spice choice than turmeric, at least at the doses studied.
Uric Acid and Gout
High uric acid is bad for kidneys. It promotes inflammation in kidney tissue and, at very high levels, can crystallize in the kidney itself. Some early-stage research has looked at whether cinnamon can lower uric acid. In hyperuricemic rats, cinnamon extract reduced uric acid levels, an effect attributed to the polyphenol cinnamaldehyde inhibiting xanthine oxidase, the enzyme responsible for producing uric acid.7Indonesian Journal of Medicine. Therapy of Cinnamon Decoction using Honey in Reducing Gout This is the same enzyme that prescription gout medications target. Whether cinnamon consumed in food or supplement form produces enough inhibition in humans to matter is unknown, and no clinical trial has tested this specific question in people with kidney disease or gout.
Cassia Versus Ceylon and Why the Distinction Matters
Not all cinnamon is the same, and the variety you use could make a meaningful difference for your kidneys. The two main types are Cassia cinnamon (the common, inexpensive kind sold in most grocery stores) and Ceylon cinnamon, sometimes called “true cinnamon.” Both contain cinnamaldehyde and the other bioactive compounds linked to potential health benefits, though Cassia bark tends to have a higher concentration of cinnamaldehyde.8Zywnosc Nauka Technologia Jakosc/Food Science Technology Quality. Quality evaluation of cinnamon marketed in Poland on the basis of determining ratio of cinnamaldehyde-to-coumarin content
The critical difference is coumarin. Cassia cinnamon contains substantial amounts of coumarin, while Ceylon cinnamon contains only traces.9PubMed. Cassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the United States Coumarin in high or sustained doses is toxic to the liver, and liver stress is the last thing someone with kidney disease needs, since the liver and kidneys share detoxification duties. When one organ is impaired, the other compensates, so overloading the liver with coumarin could compound the strain on already-compromised kidneys. European food safety authorities have set a tolerable daily intake for coumarin, and just a teaspoon or two of Cassia cinnamon per day can approach or exceed that limit. If you are considering cinnamon supplementation for any health reason and you have kidney disease, Ceylon cinnamon is the safer choice by a wide margin. The trade-off is that Ceylon is more expensive and harder to find.
Drug Interactions Worth Knowing About
People with kidney disease tend to be on multiple medications, and cinnamon can interact with some of them in ways that matter. The coumarin in Cassia cinnamon acts as a mild blood thinner, which becomes a real concern if you are already taking anticoagulant or antiplatelet drugs. A recent review flagged this specifically, noting that combining cinnamon supplementation with blood-thinning medications could amplify anticoagulant effects depending on the dose, duration, and the individual’s age and sex.10Clinical Nutrition Open Science. Cinnamon treatment shows promise for glycemic control but may cause adverse effects in some people CKD patients are often prescribed blood thinners or antiplatelet agents because of their elevated cardiovascular risk, so this overlap is not theoretical.
Cinnamon also lowers blood sugar and blood pressure, as the clinical trial evidence described earlier showed. If you are on insulin, metformin, or blood-pressure-lowering medications, adding a high-dose cinnamon supplement on top could push those numbers lower than intended. The risk is not from a pinch of cinnamon in cooking. It is from concentrated cinnamon capsules taken daily alongside prescription drugs that target the same markers. Your nephrologist or pharmacist should know about any supplement you are taking so that dosing can be adjusted if needed.
Lead Contamination in Cinnamon Products
A concern that most people do not think about is heavy metal contamination, and it is especially relevant for people with impaired kidneys. In late 2023, a safety alert was issued in the United States after children developed elevated blood lead levels from consuming apple-cinnamon fruit puree. A subsequent study analyzed 61 cinnamon samples from Ecuador and found that ground cinnamon contained nearly twice the lead concentration of cinnamon sticks, with some ground samples exceeding the maximum levels set by both Ecuadorian and European Union regulations.11PubMed. Lead content in cinnamon and its health risk assessment for Ecuadorian consumers
Lead is particularly dangerous for anyone with kidney disease. Healthy kidneys filter lead from the blood, but damaged kidneys do this less efficiently, allowing lead to accumulate and cause further harm to the kidneys themselves, the nervous system, and the cardiovascular system. The grinding process seems to introduce or concentrate lead, possibly through contaminated equipment or mixing with lower-quality material. If you use cinnamon regularly and have CKD, buying whole cinnamon sticks and grinding them yourself, or choosing brands that test for heavy metals, reduces this risk.
What to Actually Do If You Have Kidney Disease
If you are living with CKD, the honest answer is that cinnamon should not replace or delay any conventional treatment. The standard pillars of kidney care, including blood-pressure control, blood-sugar management if diabetic, dietary adjustments for sodium and potassium, and the medications your nephrologist prescribes, have vastly more evidence behind them than cinnamon does. Nothing in the cinnamon literature suggests it is powerful enough to substitute for any of those interventions.
That said, adding modest amounts of cinnamon to your food is unlikely to cause harm and could offer small metabolic benefits, particularly for blood sugar and cholesterol. Choose Ceylon cinnamon to avoid coumarin toxicity. Stick to culinary quantities rather than high-dose supplements unless your doctor specifically approves them. Be aware that ground cinnamon products carry a small but real risk of lead contamination, especially in products from less-regulated supply chains. And if you take blood thinners, diabetes medications, or blood-pressure drugs, mention any cinnamon supplementation to your care team so interactions can be monitored.
The Potassium and Phosphorus Question
People with advanced CKD often restrict potassium and phosphorus because their kidneys can no longer regulate those minerals well. A reasonable worry is whether cinnamon adds a concerning amount of either one. The answer is that cinnamon is used in such small quantities, typically a fraction of a teaspoon to a teaspoon at a time, that its mineral contribution is negligible. A teaspoon of ground cinnamon contains roughly 11 milligrams of potassium and about 2 milligrams of phosphorus, amounts too small to register against a daily limit that typically falls in the range of 2,000 to 3,000 milligrams of potassium for a restricted diet. Even if you use cinnamon daily, it will not meaningfully move the needle on your mineral intake. This sets cinnamon apart from some other plant-based supplements and spice mixtures that can contribute more substantial mineral loads. It is one of the few seasonings that CKD patients can use freely from a mineral standpoint, which is why renal dietitians often recommend it as a flavor substitute for salt.
Why the Research Gap Exists
Given how promising the animal data looks, it is fair to wonder why we do not have better human trials already. Part of the answer is funding. Cinnamon is a generic food commodity. No company can patent it and recoup the tens of millions of dollars a large-scale clinical trial would cost. That economic reality means cinnamon studies tend to be small, short, and run at academic centers with limited budgets. The 60-day diabetes trial that measured eGFR is a good example: it generated an intriguing signal, but a study of that size and duration cannot establish whether the kidney benefit is real, lasting, or clinically meaningful.
Another challenge is that CKD is slow-moving. Proving that any intervention slows kidney decline typically requires following patients for years, not weeks. The FDA-approved drugs that have recently been shown to slow CKD, such as SGLT2 inhibitors, required trials lasting two to four years with thousands of participants. No cinnamon study comes close to that scale. Until someone designs and funds a longer, larger trial specifically in CKD patients, the evidence will remain at the “biologically plausible but clinically unproven” stage. Researchers who have reviewed the literature openly acknowledge this gap while arguing that the preclinical findings are strong enough to justify the investment.